Retraction: Abnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: A meta-analysis (BioMed Research International (2014) 2014 (364207) DOI: 10.1155/2014/364207);Abnormal COX2 protein expression may be correlated with poor prognosis in oral cancer: A meta-analysis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Zhi Ming ^a   Liu, Jie ^a   Liu, Hong Bo ^a   Ye, Ming ^a   Zhang, Yu Fei ^a   Yang, Dong Sheng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PTGS2 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CINAHL; COCHRANE LIBRARY; COHORT ANALYSIS; CORRELATIONAL STUDY; DISEASE ASSOCIATION; EMBASE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); MOUTH CANCER; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WEB OF SCIENCE; BIOSYNTHESIS; DISEASE FREE SURVIVAL; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; MALE; META ANALYSIS; MORTALITY; MOUTH TUMOR; SURVIVAL RATE;

CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PUBMED; SURVIVAL RATE;

EID: 84904123443     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2021/3284807     Document Type: Erratum

References (37)

1. Brocklehurst P., Kujan O., O'Malley L. A., Ogden G., Shepherd S., Glenny A. M., Screening programmes for the early detection and prevention of oral cancer. Cochrane Database of Systematic Reviews 2013 11 CD004150 2-s2.0-79952051408
2. Warnakulasuriya S., Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 2009 45 4-5 309 316 2-s2.0-67349186933 10.1016/j.oraloncology. 2008.06.002
3. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA: Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
4. Lambert R., Sauvaget C., de Camargo Cancela M., Sankaranarayanan R., Epidemiology of cancer from the oral cavity and oropharynx. European Journal of Gastroenterology and Hepatology 2011 23 8 633 641 2-s2.0-79960698845 10.1097/MEG.0b013e3283484795
5. Chu Y. H., Tzeng S. L., Lin C. W., Chien M. H., Chen M. K., Yang S. F., Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer. PLoS ONE 2012 7 6 2-s2.0-84862994997 10.1371/journal.pone.0039777 e39777
6. Yen T. T., Lin W. D., Wang C. P., Wang C. C., Liu S. A., The association of smoking, alcoholic consumption, betel quid chewing and oral cavity cancer: a cohort study. European Archives of Oto-Rhino-Laryngology 2008 265 11 1403 1407 2-s2.0-52449127493 10.1007/s00405-008-0659-z
7. Petti S., Lifestyle risk factors for oral cancer. Oral Oncology 2009 45 4-5 340 350 2-s2.0-67349118132 10.1016/j.oraloncology.2008.05.018
8. Li T. J., Cui J., COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma. Asian Pacific Journal of Tropical Medicine 2013 6 8 640 643 2-s2.0-84879241598 10.1016/S1995-7645(13)60110-8
9. Greenhough A., Smartt H. J. M., Moore A. E., Roberts H. R., Williams A. C., Paraskeva C., Kaidi A., The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009 30 3 377 386 2-s2.0-62349138124 10.1093/carcin/bgp014
10. Carli C., Metz C. N., Al-Abed Y., Naccache P. H., Akoum A., Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways. Endocrinology 2009 150 7 3128 3137 2-s2.0-67649662617 10.1210/en.2008-1088
11. Sakurai K., Urade M., Noguchi K., Hashitani S., Takaoka K., Segawa E., Kishimoto H., Prognostic significance of cyclooxygenase-2 and DNA topoisomerase II α expression in oral carcinoma. Head and Neck 2007 29 11 1002 1009 2-s2.0-39749152903 10.1002/hed.20627
12. Wang D., Dubois R. N., The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010 29 6 781 788 2-s2.0-76849095665 10.1038/onc.2009.421
13. Looby E., Abdel-Latif M. M. M., Athié-Morales V., Duggan S., Long A., Kelleher D., Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer 2009 9, article 190 2-s2.0-67650270892 10.1186/1471-2407-9-190
14. Harris R. E., Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 2009 17 2 55 67 2-s2.0-64049109107 10.1007/s10787-009-8049-8
15. Bartchewsky W. Jr., Martini M. R., Masiero M., Squassoni A. C., Alvarez M. C., Ladeira M. S., Salvatore D., Trevisan M., Pedrazzoli J., Ribeiro M. L., Effect of Helicobacter pylori infection on IL-8, IL-1 β and COX-2 expression in patients with chronic gastritis and gastric cancer. Scandinavian Journal of Gastroenterology 2009 44 2 153 161 2-s2.0-61649095227 10.1080/00365520802530853
16. Wang X., Colby J. K. L., Rengel R. C., Fischer S. M., Clinton S. K., Klein R. D., Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes. Molecular Carcinogenesis 2009 48 1 1 13 2-s2.0-58849089319 10.1002/mc.20449
17. Baek J. Y., Hur W., Wang J. S., Bae S. H., Yoon S. K., Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest. World Journal of Gastroenterology 2007 13 8 1175 1181 2-s2.0-34247118852 (Pubitemid 46592957)
18. Atula T., Hedström J., Ristimäki A., Finne P., Leivo I., Markkanen-Leppänen M., Haglund C., Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Oncology Reports 2006 16 3 485 490 2-s2.0-33749162834
19. Cha J. D., Li S., Cha I. H., Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma. Head and Neck 2011 33 5 627 637 2-s2.0-79954479159 10.1002/hed.21507
20. Pandey M., Prakash O., Santhi W. S., Soumithran C. S., Pillai R. M., Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation. International Journal of Oral and Maxillofacial Surgery 2008 37 4 379 383 2-s2.0-41249086806 10.1016/j.ijom.2008.01.004 (Pubitemid 351446108)
21. Cao X. P., Zhang S. T., Zhou H., Wu H. Y., Liu X. J., Zhang Y. Y., Relationship between the expression of cyclooxygenase-2 and microvessel density in oral squamous cell carcinoma. West China Journal of Stomatology 2005 23 431 433
22. Sudbø J., Ristimaki A., Sondresen J. E., Kildal W., Boysen M., Koppang H. S., Reith A., Risberg B., Nesland J. M., Bryne M., Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. Oral Oncology 2003 39 5 497 505 10.1016/S1368-8375(03)00012-5 (Pubitemid 36579118)
23. Haffner M. C., Laimer J., Chaux A., Schäfer G., Obrist P., Brunner A., Kronberger I. E., Laimer K., Gurel B., Koller J., Seifarth C., Zelger B., Klocker H., Rasse M., Doppler W., Bander N. H., High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity. Modern Pathology 2012 25 8 1079 1085 2-s2.0-84864549393 10.1038/modpathol.2012. 66
24. Stang A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 2010 25 9 603 605 2-s2.0-77957661914 10.1007/s10654-010-9491-z
25. Zintzaras E., Ioannidis J. P. A., HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 2005 21 18 3672 3673 2-s2.0-24644511654 10.1093/bioinformatics/bti536 (Pubitemid 41264106)
26. Peters J. L., Sutton A. J., Jones D. R., Abrams K. R., Rushton L., Comparison of two methods to detect publication bias in meta-analysis. The Journal of the American Medical Association 2006 295 6 676 680 2-s2.0-32144440794 10.1001/jama.295.6.676 (Pubitemid 43209069)
27. Itoh S., Matsui K., Furuta I., Takano Y., Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncology 2003 39 8 829 835 2-s2.0-1642411967 10.1016/S1368-8375(03)00105-2 (Pubitemid 38373467)
28. Segawa E., Sakurai K., Kishimoto H., Takaoka K., Noguchi K., Hashitani S., Hirota S., Urade M., Expression of cyclooxygenase-2 and DNA topoisomerase II α in precancerous and cancerous lesions of the oral mucosa. Oral Oncology 2008 44 7 664 671 2-s2.0-45249106157 10.1016/j.oraloncology.2007.08.014 (Pubitemid 351842818)
29. Sawhney M., Rohatgi N., Kaur J., Shishodia S., Sethi G., Gupta S. D., Deo S. V. S., Shukla N. K., Aggarwal B. B., Ralhan R., Expression of NF- B parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. International Journal of Cancer 2007 120 12 2545 2556 2-s2.0-34247499895 10.1002/ijc.22657 (Pubitemid 46651274)
30. Tang D. W., Lin S. C., Chang K. W., Chi C. W., Chang C. S., Liu T. Y., Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell carcinoma-evidence for COX-2 induction by areca quid ingredients in oral keratinocytes. Journal of Oral Pathology and Medicine 2003 32 9 522 529 2-s2.0-0141426478 10.1034/j.1600-0714.2003.00182.x (Pubitemid 37175004)
31. Sakurai K., Urade M., Noguchi K., Kishimoto H., Ishibashi M., Yasoshima H., Yamamoto T., Kubota A., Increased expression of cyclooxygenase-2 in human salivary gland tumors. Pathology International 2001 51 10 762 769 2-s2.0-0035164852 10.1046/j.1440-1827.2001.01280.x (Pubitemid 33078394)
32. Cuzick J., Otto F., Baron J. A., Brown P. H., Burn J., Greenwald P., Jankowski J., La Vecchia C., Meyskens F., Senn H. J., Thun M., Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. The Lancet Oncology 2009 10 5 501 507 2-s2.0-65349152488 10.1016/S1470-2045(09)70035-X
33. Choi S. H., Aid S., Bosetti F., The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends in Pharmacological Sciences 2009 30 4 174 181 2-s2.0-62949176283 10.1016/j.tips.2009.01.002
34. Katoh H., Hosono K., Ito Y., Suzuki T., Ogawa Y., Kubo H., Kamata H., Mishima T., Tamaki H., Sakagami H., Sugimoto Y., Narumiya S., Watanabe M., Majima M., COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems. The American Journal of Pathology 2010 176 3 1469 1483 2-s2.0-77749304055 10.2353/ajpath.2010.090607
35. Meyer S., Vogt T., Landthaler M., Berand A., Reichle A., Bataille F., Marx A. H., Menz A., Hartmann A., Kunz-Schughart L. A., Wild P. J., Cyclooxygenase 2 (COX2) and peroxisome proliferator-activated receptor γ (PPARG) are stage-dependent prognostic markers of malignant melanoma. PPAR Research 2010 2010 11 2-s2.0-84868307362 10.1155/2010/848645 848645
36. Mrena J., Wiksten J., Kokkola A., Nordling S., Ristimäki A., Haglund C., COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. Tumor Biology 2010 31 1 1 7 2-s2.0-77951023237 10.1007/s13277-009-0001-4
37. Şahin M., Şahin E., Gümüşlü S., Cyclooxygenase-2 in cancer and angiogenesis. Angiology 2009 60 2 242 253 2-s2.0-65249138730 10.1177/0003319708318378